Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 HKD | 0.00% | -21.33% | -30.77% |
Apr. 12 | Carsgen Therapeutics To Give Cancer Drug Oral Presentation at ASCO 2024 | MT |
Mar. 26 | CARsgen Therapeutics Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on CARsgen Therapeutics Holdings Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CARsgen Therapeutics Holdings Limited
UBS |
EPS Revisions
- Stock Market
- Equities
- 2171 Stock
- Consensus CARsgen Therapeutics Holdings Limited